Fortive (FTV) Proxy filing summary

Executive summary

• Completed the separation of the Precision Technologies segment, focusing on Intelligent Operating Solutions and Advanced Healthcare Solutions, with a culture rooted in continuous improvement and the Fortive Business System.

• Launched the Fortive Accelerated strategy post-separation, emphasizing faster profitable organic growth, disciplined capital allocation, and building investor trust, with early results showing accelerating growth and strong financials in 2H 2025.

• Returned $1.6 billion to shareholders through share repurchases in 2025 and exceeded expectations in the first two quarters as the new entity.

Voting matters and shareholder proposals

• Shareholders will vote on electing eight director nominees for one-year terms, an advisory vote on executive compensation, and ratification of Ernst & Young LLP as the independent auditor for 2026.

• The Board recommends voting FOR all proposals.

• Shareholder rights include proxy access, majority voting for directors, and the right to call special meetings.

Board of directors and corporate governance

• Board consists of eight nominees with diverse skills in global leadership, technology, sustainability, finance, and risk management; 88% are independent.

• Board refreshment since 2021, fully declassified board, independent Chair, and separation of Chair and CEO roles.

• Annual self-assessment and robust shareholder engagement inform board composition and governance practices.